Medical Research Collaborative, LLC Announces Launch of Website Offering Market Research on the Global Healthcare Sector

ST. PETERSBURG, FL / ACCESSWIRE / June 3, 2019 / Medical Research Collaborative, LLC (MRC) announces the recent launch of their website, MedicalResearchCollaborative.com.

MRC offers comprehensive segmental market research that includes companies comprising the global healthcare market, segmented into product type by sponsor and by end user. By the mode of product type, the market has been segmented into finished products, active pharmaceutical ingredients and indications approved/sought. The analysis also covers barriers to entry, ongoing patent infringement proceedings, competition and loopholes available to smaller competitors. The analysis further divides amongst products and infers the likelihood and type of regulatory action.

For more information on Medical Research Collaborative reports, please visit: https://medicalresearchcollaborative.com/reports

About Medical Research Collaborative

Medical Research Collaborative, LLC, as the name implies, is a collaborative effort, bringing together expertise from various fields of scientific endeavor, as well as in matters of foreign and domestic (U.S.) patent law and regulatory science, directly applicable to a systematic, thorough analysis of companies in the healthcare sector and their products.

CONTACT

James Murphy
Executive Director of Marketing
Medical Research Collaborative, LLC
Phone: 1-877-427-1317
Email: admin@medicalresearchcollaborative.com
Web: https://medicalresearchcollaborative.com/
Source: https://medicalresearchcollaborative.com/

SOURCE: Medical Research Collaborative, LLC

View source version on accesswire.com:
https://www.accesswire.com/547472/Medical-Research-Collaborative-LLC-Announces-Launch-of-Website-Offering-Market-Research-on-the-Global-Healthcare-Sector

user

Recent Posts

AI Wellness Launches SoCal Fire Relief Initiative to Support Families and First Responders in Southern California

LOS ANGELES, Jan. 11, 2025 /PRNewswire/ -- Demonstrating a commitment to both innovation and compassion,…

8 hours ago

Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced…

23 hours ago

Matinas BioPharma Receives NYSE Noncompliance Notice

BEDMINSTER, N.J. , Jan. 10, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American:…

23 hours ago

Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Craig Swandal, experienced medical device manufacturing executive, joins leadership teamALACHUA, Fla. and TAMPA, Fla., Jan.…

23 hours ago

Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage…

23 hours ago

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”),…

23 hours ago